Angiographic predictors of left ventricular ejection fraction after successful angioplasty in acute myocardial infarction: An angiographic risk score for use in the catheterization laboratory
Corresponding Author
Jose P.S. Henriques MD, PhD,
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
Isala Klinieken, Locatie Weezenlanden, Department of Cardiology, Groot Wezenland 20, 8011 JW Zwolle, The NetherlandsSearch for more papers by this authorFelix Zijlstra MD, PhD
Department of Cardiology, Thoraxcenter, University Hospital Groningen, Groningen, The Netherlands
Search for more papers by this authorJan Paul Ottervanger MD, PhD
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
Search for more papers by this authorMenko-Jan de Boer MD, PhD
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
Search for more papers by this authorJan-Henk E. Dambrink MD, PhD
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
Search for more papers by this authorA.T. Marcel Gosselink MD, PhD
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
Search for more papers by this authorArnoud W.J. van 't Hof MD, PhD
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
Search for more papers by this authorJan C.A. Hoorntje MD, PhD
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
Search for more papers by this authorHarry Suryapranata MD, PhD
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
Search for more papers by this authorCorresponding Author
Jose P.S. Henriques MD, PhD,
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
Isala Klinieken, Locatie Weezenlanden, Department of Cardiology, Groot Wezenland 20, 8011 JW Zwolle, The NetherlandsSearch for more papers by this authorFelix Zijlstra MD, PhD
Department of Cardiology, Thoraxcenter, University Hospital Groningen, Groningen, The Netherlands
Search for more papers by this authorJan Paul Ottervanger MD, PhD
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
Search for more papers by this authorMenko-Jan de Boer MD, PhD
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
Search for more papers by this authorJan-Henk E. Dambrink MD, PhD
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
Search for more papers by this authorA.T. Marcel Gosselink MD, PhD
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
Search for more papers by this authorArnoud W.J. van 't Hof MD, PhD
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
Search for more papers by this authorJan C.A. Hoorntje MD, PhD
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
Search for more papers by this authorHarry Suryapranata MD, PhD
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
Search for more papers by this authorAbstract
We investigated the value of angiographic parameters in patients with successful primary angioplasty using a simple angiographic risk score. In 608 consecutive patients, we assessed the infarct-related artery, antegrade flow before treatment, presence of distal embolization, and myocardial blush grade after coronary angioplasty. LAD-related infarction (OR = 8.4; 3 points), TIMI 0–2 flow before angioplasty (OR = 2.2; 1 point), myocardial blush 0 or 1 (OR = 2.5; 1 point), and distal embolization (OR = 2.2; 1 point) were independent predictors of left ventricular ejection fraction (LVEF) ≤ 40% after successful angioplasty. Patients with 0 (minimum) or 1 point have LVEF of 49.5% ± 8.4% and 30-day mortality of 0.8%. Patients with 2–3 points have LVEF of 44.9% ± 10.3% and 30-day mortality of 2.8%. Patients with 4 points have LVEF of 38.2% ± 10.8% and 30-day mortality of 2.7%. Patients with 5–6 (maximum) points have LVEF of 32.0% ± 9.4% and 30-day mortality of 6.9%. A simple angiographic score predicts LVEF and mortality in patients when leaving the catheterization laboratory after successful primary angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv 2004;61:338–343. © 2004 Wiley-Liss, Inc.
REFERENCES
- 1 Mukherjee D, Moliterno DJ. Achieving tissue-level perfusion in the setting of acute myocardial infarction. Am J Cardiol 2000; 85: 39C–46C.
- 2 Hamada S, Nishiue T, Nakamura S, Sugiura T, Kamihata H, Miyoshi H, Imuro Y, Iwasaka T. TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute myocardial infarction. J Am Coll Cardiol 2001; 38: 666–671.
- 3 Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO, Gibbons RJ, Alpert JP, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith SC Jr, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): executive summary. Circulation 2001; 103: 3019–3041.
- 4 Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T. Clinical implications of the ‘no reflow’ phenomenon: a predictor of complications and left ventricular remodelling in reperfused anterior wall myocardial infarction. Circulation 1996; 93: 223–228.
- 5 Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, Blumenthal RS, Lima JA. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998; 97: 765–772.
- 6 Kondo M, Nakano A, Saito D, Shimono Y. Assessment of “microvascular no-reflow phenomenon” using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction. J Am Coll Cardiol 1998; 32: 898–903.
- 7 Brener SJ, Ellis SG, Sapp SK, Betriu A, Granger CB, Burchenal JE, Moliterno DJ, Califf RM, Topol EJ. Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trials. Am Heart J 2000; 139: 476–481.
- 8 Ottervanger JP, Van 't Hof AWJ, Reiffers S, Hoorntje JCA, Suryapranata H, de Boer MJ, Zijlstra F. Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J 2001; 22: 785–790.
- 9 Brodie BR, Stuckey TD, Hansen C, Muncy D. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol 2000; 85: 13–18.
- 10 Stone GW, Cox D, Garcia E, Muncy Dl. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation 2001; 104: 636–641.
- 11 Aueron F, Gruentzig A. Distal embolization of a coronary artery bypass graft atheroma during percutaneous transluminal coronary angioplasty. Am J Cardiol 1984; 53: 953–954.
- 12 Henriques JPS, Zijlstra F, Ottervanger JP, de Boer MJ, van 't Hof AWJ, Hoorntje JCA, Suryapranata H. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002; 23: 1112–1117.
- 13 van 't Hof AWJ, Liem A, Suryapranata H, Hoorntje JCA, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade— Zwolle Myocardial Infarction Study Group. Circulation 1998; 97: 2302–2306.
- 14 Stone GW, Peterson MA, Lansky AJ, Dangas G, Mehran R, Leon MB. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 2002; 39: 591–597.
- 15 Suryapranata H, van 't Hof AWJ, Hoorntje JCA, de Boer MJ, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998; 97: 2502–2505.
- 16 Suryapranata H, Ottervanger JP, Nibbering E, van 't Hof AWJ, Hoorntje JCA, de Boer MJ, Al MJ, Zijlstra F. Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction. Heart 2001; 85: 667–671.
- 17 de Boer MJ, Suryapranata H, Hoorntje JCA, Reiffers S, Liem AL, Miedema K, Hermens WT, van den Brand MJ, Zijlstra F. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation 1994; 90: 753–761.
- 18 St John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moye LA, Dagenais GR, Lamas GA, Klein M, Sussex B, Goldman S. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction: the protective effects of captopril. Circulation 1994; 89: 68–75.
- 19 Norris RM, White HD. Therapeutic trials in coronary thrombosis should measure left ventricular function as primary end-point of treatment. Lancet 1988; 1: 104–106.
- 20 Zijlstra F, Hoorntje JCA, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP, van 't Hof AWJ, Suryapranata H. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999; 341: 1413–1419.
- 21 Mak KH, Challapalli R, Eisenberg MJ, Anderson KM, Califf RM, Topol EJ. Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. Am J Cardiol 1997; 80: 985–988.
- 22 Neumann FJ, Blasini R, Schmitt C, Alt E, Dirschinger J, Gawaz M, Kastrati A, Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation 1998; 98: 2695–2701.
- 23 Koch KC, vom Dahl J, Kleinhans E, Klues HG, Radke PW, Ninnemann S, Schulz G, Buell U, Hanrath P. Influence of a platelet GPIIb/IIIa receptor antagonist on myocardial hypoperfusion during rotational atherectomy as assessed by myocardial Tc-99m sestamibi scintigraphy. J Am Coll Cardiol 1999; 33: 998–1004.
- 24 Brouwer MA, Verheugt FW. Oral anticoagulation for acute coronary syndromes. Circulation 2002; 105: 1270–1274.
- 25 Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox KA, CURE investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358: 527–533.
- 26 van 't Hof AWJ, Liem AL, de Boer MJ, Hoorntje JCA, Suryapranata H, Zijlstra F. A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J 1999; 20: 659–665.
- 27 Belli G, Pezzano A, De Biase AM, Bonacina E, Silva P, Salvade P, Piccalo G, Klugmann S. Adjunctive thrombus aspiration and mechanical protection from distal embolization in primary percutaneous intervention for acute myocardial infarction. Catheter Cardiovasc Interv 2000; 50: 362–370.
- 28 Stein BC, Moses J, Teirstein PS. Balloon occlusion and transluminal aspiration of saphenous vein grafts to prevent distal embolization. Catheter Cardiovasc Interv 2000; 51: 69–73.
- 29 Grube E, Gerckens U, Yeung AC, Rowold S, Kirchhof N, Sedgewick J, Yadav JS, Stertzer S. Prevention of distal embolization during coronary angioplasty in saphenous vein grafts and native vessels using porous filter protection. Circulation 2001; 104: 2436–2441.